Elanco Animal Health plans to restructure

Elanco Animal Health is in the process of restructuring, in an effort to streamline its international operations.In a filing with the U.S. Securities and Exchange Commission (SEC), Elanco stated that its board of directors on December 10 authorized a restructuring program that will shift its focus and resources to priority areas.The proposed restructuring reflects a change from having a physical location to a distribution model in certain countries, in connection to Elanco’s recent spinoff from that of parent company Eli Lilly & Company and initial public offering (IPO), according to the SEC filing.The SEC filing further stated that as part of Elanco’s ongoing efforts in connection with its separation from Eli Lilly & Company, the board authorized the write-off of certain assets that will not be utilized in the business on an ongoing basis.